R. Villano et al. / Tetrahedron 65 (2009) 5571–5576
5575
for 24 h at room temperature, and then dry THF (2 ml) was added.
This solution was cooled at ꢀ78 ꢁC and TFA (0.2 ml) was added
dropwise, then it was permitted to warm to room temperature and
after completion of the desilylation reaction, it was neutralized by
addition of saturated aq NaHCO3. The reaction mixture was
extracted with AcOEt and the combined organic phase was dried
(MgSO4) and concentrated. The residue was purified by non-flash
chromatography (petroleum ether/AcOEt from 8:2 to 1:1) to give
the products 3 and 4.
The same procedure was used for the other chiral hydrogen
bonding donors (Tables 3 and 4) and for non-asymmetric vinylogous
reactions by omitting the employment of the chiral donor (Table 2).
The spectroscopic (IR, 1H NMR and 13C NMR) data of aldols 3a,3a
3b,3a 3c,12 3d,17 3f,12 3g,12 3h16 and 3k17 matched the ones reported
in the literature.
major enantiomer tR¼28.0; (3j): yellow oil, m/z: 248 [MþH]þ, 270
[MþNa]þ; IR (KBr, neat) 3465, 2955, 2226, 1745, 1716, 1325–1065;
1H NMR (CDCl3, 400 MHz):
d 7.65 (3H, m), 7.38 (1H, m), 5.52 (1H,
dd, J¼9.5, 2.4 Hz), 3.74 (3H, s), 3.54 (2H, s), 3.08 (1H, dd, J¼17.7,
2.4 Hz), 2.94 (1H, dd, J¼17.7, 9.5 Hz); 13C NMR (CDCl3, 400 MHz):
d
202.2, 167.0, 145.8, 133.2,132.8, 128.0, 126.6, 117.1, 109.6, 67.6, 52.5,
50.2, 49.3; enantiomeric excess was determined by HPLC (Chir-
alpak AD), hexane/iPrOH 80:20, 0.8 ml/min, major enantiomer
tR¼11.6, minor enantiomer tR¼14.3; (4j): yellow oil, m/z: 230
[MþH]þ, 252 [MþNa]þ; IR (KBr, neat) 2923, 2853, 2226, 1658, 1586,
1449, 1254; 1H NMR (CDCl3, 400 MHz):
d 7.69 (3H, m), 7.51 (1H, m),
5.83 (1H, dd, J¼13.6, 3.6 Hz), 5.00 (1H, s), 3.85 (3H, s), 2.84 (1H, dd,
J¼16.7, 13.6 Hz), 2.70 (1H, dd, J¼16.7, 3.6 Hz); 13C NMR (CDCl3,
400 MHz): d 190.5,173.6,140.4, 133.4,129.5,126.9,116.5,110.9, 83.0,
78.8, 56.1, 41.1; enantiomeric excess was determined by HPLC
(Chiralcel OD), hexane/iPrOH 95:5, 0.8 ml/min, minor enantiomer
tR¼97.0, major enantiomer tR¼101.5; (3k):17 enantiomeric excess
was determined by HPLC (Chiralpak AD), hexane/EtOH 95:5þ0.1%
TFA, 0.5 ml/min, major enantiomer tR¼132.3, minor enantiomer
tR¼140.6; (4k): yellow oil, m/z: 230 [MþH]þ; IR (KBr, neat) 2923,
2229, 1653, 1586, 1450, 1273–1181; 1H NMR (CDCl3, 400 MHz):
4.3. Spectral data of new compounds
All new compounds were fully characterized on the basis of IR,
1H NMR, 13C NMR and mass spectroscopic data. Spectral data of
selected compounds: (3f):12 enantiomeric excess was determined
by HPLC (Chiralpak AD), hexane/EtOH 95:5þ0.1% TFA, 1 ml/min
major enantiomer (R) tR¼23.3, minor enantiomer (S) tR¼30.3;
(3g):12 enantiomeric excess was determined by HPLC (Chiralpak
AD), hexane/EtOH 95:5þ0.1% TFA, 1 ml/min, major enantiomer (R)
tR¼29.4, minor enantiomer (S) tR¼42.3; (3h):16 enantiomeric excess
was determined by HPLC (Chiralpak AD), hexane/EtOH 95:5þ0.1%
TFA, 1 ml/min minor enantiomer tR¼21.2, major enantiomer
tR¼23.5; (3c):12 enantiomeric excess was determined by HPLC
(Chiralcel OD), hexane/iPrOH 90:10, 0.8 ml/min, minor enantiomer
(S) tR¼48.0, major enantiomer (R) tR¼53.0; (4c): yellow oil, m/z: 250
[MþH]þ, 272 [MþNa]þ; IR (KBr, neat) 2922, 1656, 1583, 1521, 1450,
d
7.73 (2H, d, J¼8.2 Hz), 7.53 (2H, d, J¼8.2 Hz), 5.56 (1H, dd, J¼13.0,
3.9 Hz), 4.97 (1H, s), 3.85 (3H, s), 2.76 (1H, dd, J¼16.7, 13.0 Hz), 2.66
(1H, dd, J¼16.7, 3.9 Hz); 13C NMR (CDCl3, 400 MHz):
d 190.7, 173.7,
142.3, 132.7, 126.5, 118.1, 112.8, 82.8, 79.9, 56.1, 41.9; enantiomeric
excess was determined by HPLC (Chiralcel OD), hexane/iPrOH
90:10, 0.8 ml/min, minor enantiomer tR¼73.8, major enantiomer
tR¼83.0; (3l): yellow oil, m/z: 280 [MþNa]þ; IR (KBr, neat) 3467,
2956, 2923, 1744, 1716, 1529, 1499, 1357, 1240–1021; 1H NMR
(CDCl3, 300 MHz):
d
7.28 (1H, d, J¼3.7 Hz), 6.58 (1H, d, J¼3.7 Hz),
5.25 (1H, m), 3.75 (3H, s), 3.55 (2H, s), 3.18 (2H, m); 13C NMR (CDCl3,
300 MHz):
d 202.2, 167.6, 157.2, 113.1, 110.4, 64.4, 53.3, 49.9, 47.9;
1394, 1231; 1H NMR (CDCl3, 400 MHz):
d
8.28 (2H, d, J¼8.6 Hz), 7.59
(4l): yellow oil, m/z: 240 [MþH]þ; IR (KBr, neat) 2924, 2853, 1656,
(2H, d, J¼8.6 Hz), 5.61 (1H, dd, J¼12.9, 3.9 Hz), 4.98 (1H, s), 3.86 (3H,
1586, 1505, 1449, 1393, 1234; 1H NMR (CDCl3, 300 MHz):
d 7.30 (1H,
s), 2.77 (1H, dd, J¼16.8, 12.9 Hz), 2.68 (1H, dd, J¼16.8, 3.9 Hz); 13C
d, J¼3.6 Hz), 6.70 (1H, d, J¼3.6 Hz), 5.61 (1H, dd, J¼11.5, 4.2 Hz),
NMR (CDCl3, 400 MHz):
d 190.6, 173.7, 148.0, 144.1, 126.6, 124.1,
4.95 (1H, s), 3.83 (3H, s), 2.99 (1H, dd, J¼16.8, 11.5 Hz), 2.78 (1H, dd,
82.8, 79.7, 56.2, 42.0; enantiomeric excess was determined by HPLC
(Chiralcel OD), hexane/iPrOH 90:10, 0.8 ml/min, minor enantiomer
tR¼84.9, major enantiomer tR¼113.6; (3e): yellow oil, m/z: 290
[MþNa]þ; IR (KBr, neat) 3507, 2957, 1745,1716,1526,1345–1077; 1H
J¼16.8, 4.2 Hz); 13C NMR (CDCl3, 300 MHz):
d 190.1, 173.5, 152.6,
113.0, 112.2, 83.7, 73.5, 57.0, 38.4; enantiomeric excess was de-
termined by HPLC (Chiralcel OD), hexane/iPrOH 90:10, 0.8 ml/min,
minor enantiomer tR¼89.5, major enantiomer tR¼99.1.
NMR (CDCl3, 400 MHz):
d
7.96 (1H, d, J¼8.2 Hz), 7.89 (1H, d,
J¼7.8 Hz), 7.67 (1H, m), 7.44 (1H, m), 5.70 (1H, dd, J¼9.2, 1.9 Hz),
3.75 (3H, s), 3.55 (2H, s), 3.22 (1H, dd, J¼17.7, 1.9 Hz), 2.87 (1H, dd,
Acknowledgements
J¼17.7, 9.2 Hz); 13C NMR (CDCl3, 400 MHz):
d 202.4, 167.1, 147.0,
`
We are grateful to Universita di Salerno for financial support.
138.0, 133.8, 128.4, 128.1, 124.4, 65.4, 52.5, 50.7, 49.2; enantiomeric
excess was determined by HPLC (Chiralcel OD), hexane/iPrOH
90:10, 0.8 ml/min, minor enantiomer tR¼28.0, major enantiomer
tR¼31.4; (4e): yellow oil, m/z: 250 [MþH]þ; IR (KBr, neat) 2923,
2853, 1659, 1590, 1527, 1449, 1395–1054; 1H NMR (CDCl3,
References and notes
1. For recent reviews: (a) Langer, P. Synthesis 2002, 441–459; (b) Feist, H.; Langer, P.
Synthesis 2007, 327–347.
400 MHz):
d
8.05 (1H, d, J¼8.2 Hz), 7.84 (1H, d, J¼7.6 Hz), 7.74 (1H,
2. For recent reviews: (a) Kalesse, M. Top. Curr. Chem. 2005, 244, 43–76; (b) Sor-
iente, A.; De Rosa, M.; Villano, R.; Scettri, A. Curr. Org. Chem. 2004, 8, 993–1007;
(c) Casiraghi, G.; Zanardi, F.; Appendino, G.; Rassu, G. Chem. Rev. 2000, 100,
1929–1972; (d) Denmark, S. E.; Heemstra, J. R., Jr.; Beutner, G. L. Angew. Chem.,
Int. Ed. 2005, 44, 4682–4698.
m), 7.56 (1H, m), 6.15 (1H, dd, J¼13.4, 3.3 Hz), 4.99 (1H, s), 3.83 (3H,
s), 2.94 (1H, dd, J¼16.8, 3.3 Hz), 2.71 (1H, dd, J¼16.8, 13.4 Hz); 13C
NMR (CDCl3, 400 MHz):
d 190.9, 173.7, 147.3, 134.7, 134.0, 129.6,
3. (a) Soriente, A.; De Rosa, M.; Stanzione, M.; Villano, R.; Scettri, A. Tetrahedron:
Asymmetry 2001, 12, 959–963; (b) Soriente, A.; De Rosa, M.; Villano, R.; Scettri,
A. Tetrahedron: Asymmetry 2000, 11, 2255–2258; (c) Villano, R.; Acocella, M. R.;
De Rosa, M.; Soriente, A.; Scettri, A. Tetrahedron: Asymmetry 2004, 15, 2421–
2424.
127.9, 124.9, 83.0, 65.4, 56.1, 41.7; enantiomeric excess was de-
termined by HPLC (Chiralcel OD), hexane/iPrOH 90:10, 0.8 ml/min,
minor enantiomer tR¼40.4, major enantiomer tR¼44.0; (3d):17 en-
antiomeric excess was determined by HPLC (Chiralpak AD), hex-
ane/EtOH 95:5þ0.1% TFA, 1 ml/min, major enantiomer tR¼15.9,
minor enantiomer tR¼17.5; (4d): yellow oil, m/z: 273 [MþH]þ; IR
(KBr, neat) 2922, 2852, 1653, 1580, 1452, 1326, 1253–1124; 1H NMR
4. Gardner, J. M.; Kono, Y.; Tatum, J. H.; Suzuki, Y.; Takeuchi, S. Phytochemistry
1985, 24, 2861–2867.
5. Savard, J.; Brassard, P. Tetrahedron Lett. 1979, 20, 4911–4914.
6. (a) Lin, L.; Chen, Z.; Yang, X.; Liu, X.; Feng, X. Org. Lett. 2008, 10, 1311–1314; (b)
Fan, Q.; Lin, L.; Liu, J.; Huang, Y.; Feng, X.; Zhang, G. Org. Lett. 2004, 6, 2185–
2188; (c) Fan, Q.; Lin, L.; Liu, J.; Huang, Y.; Feng, X. Eur. J. Org. Chem. 2005, 3542–
3552; (d) Lin, L.; Fan, Q.; Qin, B.; Feng, X. J. Org. Chem. 2006, 71, 4141–4146.
7. Du, H.; Zhao, D.; Ding, K. Chem.dEur. J. 2004, 10, 5964–5970.
8. For recent reviews: (a) Dalko, P. I.; Moisan, L. Angew. Chem., Int. Ed. 2004, 43,
5138–5175; (b) Houk, K. N., List, B., Eds. Acc. Chem. Res. 2004, 37, 487–631,
special issue; (c) Brandes, S.; Niess, B.; Bella, M.; Prieto, A.; Overgaard, J.;
Jørgensen, K. A. Chem.dEur. J. 2006, 12, 6039–6052; (d) Notz, W.; Tanaka, F.;
(CDCl3, 400 MHz):
d
7.69 (2H, d, J¼8.0 Hz), 7.53 (2H, d, J¼8.0 Hz),
5.56 (1H, dd, J¼13.4, 3.5 Hz), 4.97 (1H, s), 3.84 (3H, s), 2.79 (1H, dd,
J¼16.7, 13.4 Hz), 2.65 (1H, dd, J¼16.7, 3.5 Hz); 13C NMR (CDCl3,
400 MHz):
d 191.1, 173.8, 145.0, 141.1, 126.2, 125.8, 108.2, 82.8, 80.3,
56.0, 42.0; enantiomeric excess was determined by HPLC (Chiralcel
OD), hexane/iPrOH 90:10, 0.8 ml/min, minor enantiomer tR¼22.8,